Published TCIMAIL newest issue No.201 | Product Document Searching Made Easy by 2D Code! | TCI Chemistry News March 2026 | [Product Highlights] Ionic Liquid and Zinc Compound Used... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 51333-22-3 | 产品编码: B3909
Budesonide
| 产品编码 | B3909 |
纯度/分析方法
|
>98.0%(HPLC) |
| 分子式/分子量 | C__2__5H__3__4O__6 = 430.54 |
| 外观与形状(20°C) | 固体 |
储存温度
|
室温 (15°C以下阴凉干燥处) |
包装和容器
|
1G-Glass Bottle with Plastic Insert (查看图片), 200MG-Glass Bottle with Plastic Insert (查看图片) |
| CAS RN | 51333-22-3 |
| Reaxys-RN | 3633996 |
| PubChem物质ID | 160871371 |
| Merck Index (14) | 1468 |
| MDL编号 | MFCD00083259 |
技术规格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 % (total of isomers) |
| Elemental analysis(Carbon) | 68.00 to 71.00 % |
| Specific rotation [a]20/D | +100 to +110 deg(C=0.28、CH2Cl2) |
物性(参考值)
| 比旋光度 [α]D | 105° (C=0.28,CH2Cl2) |
| 水溶性 | 不溶 |
| 溶解性(可溶于) | 甲醇, 氯仿 |
| 溶解性(微溶于) | 丙酮, 乙醇 |
GHS
| 象形图 |
|
| 信号词 | Warning |
| 危险性说明 | H315 : Causes skin irritation. |
| 防范说明 | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves. P302 + P352 : IF ON SKIN: Wash with plenty of water. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
相关法规
| RTECS# | TU3723000 |
运输信息
| HS编码* | 2937.29-000 |
应用
Budesonide: A Potent Glucocorticoid Receptor Antagonist
Budesonide is an anti-inflammatory corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity.1-6) Budesonide has a strong affinity for glucocorticoid receptor, and it is reported that budesonide has approximately 8.5-fold, 15-fold, and 195-fold greater than those of dexamethasone [D1961], prednisolone [P0637], and hydrocortisone [H0533], respectively.6) Budesonide is mainly metabolized by CYP3A4.6) (The product is for research purpose only.)
References
- 1)Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids(a review)
- 2)Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis(a review)
- 3)Budesonide: A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease(a review)
- 4)Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease(a review)
- 5)Treatment of inflammatory bowel disease: a review of medical therapy(a review)
- 6)Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis (a review)
PubMed Literature
文档
技术文章
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。